富祥药业: 募集资金管理制度

Core Viewpoint - The document outlines the management and usage of raised funds by Jiangxi Fuxiang Pharmaceutical Co., Ltd., emphasizing the establishment of a clear investment management system to ensure the safety and efficiency of fund usage while protecting the rights of the company and its shareholders [1][2]. Fund Management System - The company must establish a system for the storage, usage, modification, supervision, and accountability of raised funds, including clear approval authority and risk control measures [1][2]. - The board of directors is responsible for ensuring the effective implementation of this system [2][4]. Fund Storage Management - Raised funds must be stored in a special account approved by the board of directors, and these accounts should not hold non-raised funds or be used for other purposes [2][3]. - A tripartite supervision agreement must be signed between the company, the sponsoring institution, and the commercial bank where the funds are stored [3][4]. Fund Usage Management - Funds must be used according to the investment plan outlined in the issuance application documents, and any significant deviations must be reported to the Shenzhen Stock Exchange [5][6]. - The company is prohibited from using raised funds for financial investments, such as trading financial assets or lending to others [6][7]. Fund Usage Change - Changes in the use of raised funds require board and shareholder approval, and the company must conduct feasibility analyses for new projects [18][19]. - If the remaining funds from completed projects are less than 5% of the net amount raised, the company may use them for other purposes without going through the usual approval process [14]. Supervision and Reporting - The board must conduct a comprehensive review of the progress of investment projects every six months and report on the storage and usage of raised funds [24][25]. - The sponsoring institution is required to conduct on-site inspections of the fund management every six months and issue a special verification report annually [25][26].